Tradestie Institutional Equity Comparison Engine

IRWD vs TLPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IRWD Overall Edge

IRWD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TLPH counters with relative strength in Valuation. Fundamentally, IRWD trades at 12.3x Forward P/E with 62.9% operating margin (+9.0% YoY revenue) versus TLPH at 1.0x Forward P/E and -1474700.0% operating margin (+0.0% YoY). In options structure, IRWD sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against TLPH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TLPH
IRWD 12.3x vs TLPH 1.0x Fwd P/E
Growth & Margin Winner IRWD
Op Margin 62.9% vs -1474700.0% ยท YoY +9.0% vs +0.0%
Momentum & Technical Winner IRWD
1Y +44.2% vs -18.0% ยท 52W Pos 68% vs 20%
Options & Structure Winner IRWD
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (100th %ile IV)
IRWD NASDAQ
Ironwood Pharmaceuticals, Inc. - Class A
Pharmaceutical Preparations
$4.86
+0.62% 1D
Market Cap $802.9M
1M Return +38.86%
1Y Return +44.21%
Forward P/E 12.3x
Unified AI Score
35.0 / 100 SELL
Tech 50.0 Fund 34.0 Flow 66.0 Mom 40.0
TLPH NASDAQ
Talphera, Inc. Common Stock
Pharmaceutical Preparations
$0.86
-4.98% 1D
Market Cap $53.7M
1M Return -20.29%
1Y Return -18.01%
Forward P/E 1.0x
Unified AI Score
37.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IRWD +44.21% TLPH -18.01% Spread: +62.22 pp (IRWD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IRWD TTM Op. Margin: 62.9% TLPH TTM Op. Margin: -1474700.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IRWD vs TLPH. Trailing 12-month operating profitability (IRWD 62.9% vs TLPH -1474700.0%) and valuation multiples (IRWD 12.3x vs TLPH 1.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IRWD (6) vs TLPH (4)
Institutional Metric IRWD TLPH Criterion Row Winner
Market Capitalization Scale $802.9M $53.7M Larger Scale IRWD
Trailing P/E Ratio Valuation 5.4x 1.0x Lower Multiple TLPH
Forward P/E Ratio Valuation 12.3x 1.0x Lower Multiple TLPH
Revenue Growth (YoY) Growth +9.0% +0.0% Higher Growth IRWD
Operating Margin (TTM) Profitability 62.9% -1474700.0% Higher Margin IRWD
Net Profit Margin Profitability 37.4% 0.0% Higher Margin IRWD
Return on Equity (ROE) Capital Efficiency -574.7% -143.4% Higher ROE TLPH
52-Week Range Position Momentum 68% ($3โ€“$6) 20% ($1โ€“$2) Stronger Trend IRWD
Beta / 30D Volatility Risk Regime 1.37ฮฒ ยท 54% Vol 1.11ฮฒ ยท 58% Vol Lower Realized Risk IRWD
Unified Institutional Score Composite Signal 35.0 / 100 (SELL) 37.1 / 100 (SELL) Higher Composite TLPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IRWD vs TLPH Buy Guide
IRWD CONSOLIDATION
134d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live IRWD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live TLPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IRWD nor TLPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.